These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17405496)

  • 21. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD; Faber H; Fahramand P; Schacht E
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
    Nakayama H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
    [No Abstract]   [Full Text] [Related]  

  • 23. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
    Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate Phase III Osteoporosis Treatment Research Group.
    Shiraki M; Kushida K; Fukunaga M; Kishimoto H; Taga M; Nakamura T; Kaneda K; Minaguchi H; Inoue T; Morii H; Tomita A; Yamamoto K; Nagata Y; Nakashima M; Orimo H
    Osteoporos Int; 1999; 10(3):183-92. PubMed ID: 10525709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
    Schacht E; Richy F; Reginster JY
    J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).
    Shiraki M; Kuroda T; Miyakawa N; Fujinawa N; Tanzawa K; Ishizuka A; Tanaka S; Tanaka Y; Hosoi T; Itoi E; Morimoto S; Itabashi A; Sugimoto T; Yamashita T; Gorai I; Mori S; Kishimoto H; Mizunuma H; Endo N; Nishizawa Y; Takaoka K; Ohashi Y; Ohta H; Fukunaga M; Nakamura T; Orimo H
    J Bone Miner Metab; 2011 Jan; 29(1):37-43. PubMed ID: 20461422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of glucocorticoid-induced osteoporosis in patients with primary glomerulonephritis].
    Chen H; Wang M
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2207-10. PubMed ID: 16321186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alendronate].
    Okazaki R
    Clin Calcium; 2008 Oct; 18(10):1410-6. PubMed ID: 18830037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
    Saag KG; Emkey R; Schnitzer TJ; Brown JP; Hawkins F; Goemaere S; Thamsborg G; Liberman UA; Delmas PD; Malice MP; Czachur M; Daifotis AG
    N Engl J Med; 1998 Jul; 339(5):292-9. PubMed ID: 9682041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
    Schacht E; Dukas L; Richy F
    J Musculoskelet Neuronal Interact; 2007; 7(2):174-84. PubMed ID: 17627088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
    Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
    J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity of prevention of glucocorticoid-induced alveolar bone loss in rat by either calcitonin or alendronate administration.
    Ezzat BA
    Arch Oral Biol; 2010 Oct; 55(10):788-96. PubMed ID: 20728871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practice Gaps. Improving the care of our patients who are receiving glucocorticoid therapy.
    Albrecht J; Werth VP
    Arch Dermatol; 2012 Mar; 148(3):314-5. PubMed ID: 22431773
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Eastell R; Chen P; Saag KG; Burshell AL; Wong M; Warner MR; Krege JH
    Bone; 2010 Apr; 46(4):929-34. PubMed ID: 20060078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].
    Soen S
    Nihon Rinsho; 2009 May; 67(5):985-90. PubMed ID: 19432121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Doga M; Mazziotti G; Bonadonna S; Patelli I; Bilezikian JP; Canalis E; Giustina A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):53-8. PubMed ID: 18791353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].
    Eiken PA; Abrahamsen B
    Ugeskr Laeger; 2009 Mar; 171(11):903-6. PubMed ID: 19278615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.